EU - OHE - Page 37

Office of Health Economics

Leading intellectual authority on global health economics

Search publications, topics, authors and more

Newsletter SignupSubscribe

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Health Care Systems
Policy, Organisation and…

Reducing Harm to Patients in the National Health Service. Will the Government’s Compensation Proposals Help?

Emerging Markets
Policy, Organisation and…
Mental Health

Mental Health Economics and Policy in a Global Context

Health Technology Assessment…
Measuring and Valuing Outcomes

Statistical Methods for Cost-Effectiveness Research: A Guide to Current Issues and Future Developments

Health Care Systems
Policy, Organisation and…
Primary Care

Quality in Primary Care: Economic Approaches to Analysing Quality-Related Physician Behaviour

Real World Evidence (RWE)
Economics of Innovation
Research Funding

Institutions for Industrial Competitiveness in the International Pharmaceutical Industry

Real World Evidence (RWE)
Economics of Innovation
Infectious Diseases

Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty

Policy, Organisation and…
Health Policy and Regulation

Making the best of the Private Finance Initiative in the NHS

Health Care Systems
Policy, Organisation and…
Healthcare Delivery

Influencing Prescribing in a Primary Care Led NHS

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing

Tag

Select the product option you would like to filter Tag

Adult Immunisation Alzheimer's Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Saudi Arabia Slovak Republic Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Lishani Ramanayake Sukanya Subramaniyan Brittany Darrow Henry Fong Yi Wang Chittawan Poonsiri Manit Sittimart Sarin Kc Hannah Hussain Dr. Sabine Vogler

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

News
January 2017

Comparing the Cancer-Specific EORTC-8D and the Generic EQ-5D-3L

News
January 2017

Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico

EQ-5D and PROMs
Measuring and Valuing Outcomes
Clinical Outcomes

Age and Utilities: Issues for HTA

Value, Affordability, and…
Determining Value

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

Health Technology Assessment…
Measuring and Valuing Outcomes

How can HTA meet the needs of health system and government decision makers?

Health Technology Assessment…
Value, Affordability, and…

Transferability of HTA

Health Technology Assessment…
Value, Affordability, and…

HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?

Cell and Gene Therapies
Value, Affordability, and…

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

Market Access

Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries

EQ-5D and PROMs
Measuring and Valuing Outcomes
Clinical Outcomes

Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets

Measuring and Valuing Outcomes
Clinical Outcomes

What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?

Cell and Gene Therapies
Value, Affordability, and…

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

Health Care Systems
Policy, Organisation and…
Quality of Care

Delivering an Outcomes-based NHS: Creating the Right Conditions

Emerging Markets
Measuring and Valuing Outcomes
Economic Evaluation

Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study

Emerging Markets
Value, Affordability, and…
Economic Evaluation

Policy Options for Formulary Development in Middle-income Countries

News
December 2016

New OHE Research Paper: Extrapolation from Progression Free Survival to Overall Survival in Oncology

Leading intellectual authority on global health economics

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Cookies Policy

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Twitter

Facebook

Copy

Share on Mastodon

Enter your Mastodon instance URL (optional)

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!